Eckert & Ziegler SE (ETR:EUZ)
15.14
+0.15 (1.00%)
At close: Mar 6, 2026
Eckert & Ziegler SE Employees
Eckert & Ziegler SE had 1,112 employees as of September 30, 2025. The number of employees decreased by 31 or -2.71% compared to the same quarter last year.
Employees
1,112
Change
-31
Growth
-2.71%
Revenue / Employee
€273,805
Profits / Employee
€35,749
Market Cap
947.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 1,112 | -31 | -2.71% |
| Jun 30, 2025 | 1,098 | 13 | 1.20% |
| Mar 31, 2025 | 1,094 | 22 | 2.05% |
| Dec 31, 2024 | 1,085 | 10 | 0.93% |
| Sep 30, 2024 | 1,143 | 81 | 7.63% |
| Jun 30, 2024 | 1,085 | 49 | 4.73% |
| Mar 31, 2024 | 1,072 | 64 | 6.35% |
| Dec 31, 2023 | 1,075 | 99 | 10.14% |
| Sep 30, 2023 | 1,062 | 117 | 12.38% |
| Jun 30, 2023 | 1,036 | 79 | 8.25% |
| Mar 31, 2023 | 1,008 | 78 | 8.39% |
| Dec 31, 2022 | 976 | 110 | 12.70% |
| Sep 30, 2022 | 945 | 79 | 9.12% |
| Jun 30, 2022 | 957 | 114 | 13.52% |
| Mar 31, 2022 | 930 | 87 | 10.32% |
| Dec 31, 2021 | 866 | 38 | 4.59% |
| Mar 31, 2021 | 843 | 15 | 1.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,356 |
| Bayer Aktiengesellschaft | 88,502 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 62,346 |
| RHÖN-KLINIKUM Aktiengesellschaft | 19,041 |
| Gerresheimer AG | 13,535 |
| Carl Zeiss Meditec AG | 5,784 |
| SCHOTT Pharma AG & Co. KGaA | 4,829 |
Eckert & Ziegler SE News
- 1 day ago - EQS-Adhoc: Eckert & Ziegler Plans Dividend of € 0.22 per Share for 2025 - Wallstreet:Online
- 11 days ago - EQS-AFR: Eckert & Ziegler SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 11 days ago - EQS-AFR: Eckert & Ziegler SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 4 weeks ago - Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY • news - Onvista
- 7 weeks ago - Eckert & Ziegler SE at JPMorgan Healthcare Conference Transcript - GuruFocus
- 3 months ago - EQS-News: Reorganization of the Eckert & Ziegler Executive Board - Wallstreet:Online
- 3 months ago - EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 3 months ago - Eckert & Ziegler To Supply SK Biopharmaceuticals With Actinium-225 To Boost Research, Development - Finanz Nachrichten